Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate

US11203593B2 · kind B2 · utility

Assignee

• Adverio Pharma GmbH · DE

Inventors

• Birgit Keil · Düsseldorf, DE
• Franz-Josef Mais · Düsseldorf, DE
• Winfried Joentgen · Neunburg vorm Wald, DE
• Alfons Grunenberg · Wuppertal, DE

Key dates

• Filing date: Apr 14, 2020
• Grant date: Dec 21, 2021
• Expiry date: Apr 14, 2040

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P13/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This present invention relates to forms of methyl {4.6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3.4-b]pyridino-3-yl]pyrimidino-5-yl}methylcarbamate comprising its Modification I. Modification II. mono-DMSO solvate. sesqui-DMSO solvate and ¼-ethyl acetate solvate.